• Home
  • About Us
  • Events
  • Submissions
  • Advertise
  • Contact Us
  • NewsVoir
  • Newswire
  • Nasheman Urdu ePaper

Nasheman

India's largest selling Urdu weekly, now also in English

  • News & Politics
    • India
    • Indian Muslims
    • Muslim World
  • Culture & Society
  • Opinion
  • In Focus
  • Human Rights
  • Photo Essays
  • Multimedia
    • Infographics
    • Podcasts
You are here: Home / News & Politics / India / Mass production of COVID-19 vaccine to begin in India once scientists give nod: PM

Mass production of COVID-19 vaccine to begin in India once scientists give nod: PM

August 15, 2020 by Nasheman

Modi said whenever there is talk of COVID-19, the question that comes to everyone’s mind is that when will a vaccine be ready.

NEW DELHI: Prime Minister Narendra Modi on Saturday said mass production of vaccine for COVID-19 will begin in India once scientists give their nod, and a roadmap was ready to ensure it reaches everyone in the country in the shortest possible time.

Addressing the nation from the ramparts of the Red Fort on India’s 74th Independence Day, Modi said three vaccine candidates are in different stages of trials in the country, adding the talent of our scientists is like that of ‘rishi munis’.

He said whenever there is talk of COVID-19, the question that comes to everyone’s mind is that when will a vaccine be ready.

“I want to tell people, the talent of our scientists is like that of ‘rishi munis’ and they are working very hard in laboratories. Three vaccines are in various stages of testing. When scientists will give us the green signal, there will be production on a mass scale and all preparations have been made for it,” Modi said.

A roadmap has been prepared to ensure that the vaccine reaches everyone in the country in the shortest possible time with mass production, he said.

Three vaccine candidates are in different stages of human clinical trials in India.

The phase-1 and 2 human clinical trials of two of them, developed indigenously by Bharat Biotech, in collaboration with the Indian Council of Medical Research(ICMR), and Zydus Cadila Ltd, are currently underway.

The Serum Institute of India has been permitted for conducting Phase 2 and 3 human clinical trials of the third vaccine candidate developed by the Oxford University.

The Pune-based institute has partnered with AstraZeneca for manufacturing the vaccine.

Share this:

  • Tweet
  • Print
  • WhatsApp

Related

Filed Under: India

About Nasheman

Follow Us

  • Facebook
  • Twitter
  • YouTube

KNOW US

  • About Us
  • Corporate News
  • FAQs
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh

GET INVOLVED

  • Corporate News
  • Letters to Editor
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh
  • Submissions

PROMOTE

  • Advertise
  • Corporate News
  • Events
  • NewsVoir
  • Newswire
  • Realtor arrested for NRI businessman’s murder in Andhra Pradesh

Archives

  • May 2025 (9)
  • April 2025 (50)
  • March 2025 (35)
  • February 2025 (34)
  • January 2025 (43)
  • December 2024 (83)
  • November 2024 (82)
  • October 2024 (156)
  • September 2024 (202)
  • August 2024 (165)
  • July 2024 (169)
  • June 2024 (161)
  • May 2024 (107)
  • April 2024 (104)
  • March 2024 (222)
  • February 2024 (229)
  • January 2024 (102)
  • December 2023 (142)
  • November 2023 (69)
  • October 2023 (74)
  • September 2023 (93)
  • August 2023 (118)
  • July 2023 (139)
  • June 2023 (52)
  • May 2023 (38)
  • April 2023 (48)
  • March 2023 (166)
  • February 2023 (207)
  • January 2023 (183)
  • December 2022 (165)
  • November 2022 (229)
  • October 2022 (224)
  • September 2022 (177)
  • August 2022 (155)
  • July 2022 (123)
  • June 2022 (190)
  • May 2022 (204)
  • April 2022 (310)
  • March 2022 (273)
  • February 2022 (311)
  • January 2022 (329)
  • December 2021 (296)
  • November 2021 (277)
  • October 2021 (237)
  • September 2021 (234)
  • August 2021 (221)
  • July 2021 (237)
  • June 2021 (364)
  • May 2021 (282)
  • April 2021 (278)
  • March 2021 (293)
  • February 2021 (192)
  • January 2021 (222)
  • December 2020 (170)
  • November 2020 (172)
  • October 2020 (187)
  • September 2020 (194)
  • August 2020 (61)
  • July 2020 (58)
  • June 2020 (56)
  • May 2020 (36)
  • March 2020 (48)
  • February 2020 (109)
  • January 2020 (162)
  • December 2019 (174)
  • November 2019 (120)
  • October 2019 (104)
  • September 2019 (88)
  • August 2019 (159)
  • July 2019 (122)
  • June 2019 (66)
  • May 2019 (276)
  • April 2019 (393)
  • March 2019 (477)
  • February 2019 (448)
  • January 2019 (693)
  • December 2018 (736)
  • November 2018 (572)
  • October 2018 (611)
  • September 2018 (692)
  • August 2018 (667)
  • July 2018 (469)
  • June 2018 (440)
  • May 2018 (616)
  • April 2018 (774)
  • March 2018 (338)
  • February 2018 (159)
  • January 2018 (189)
  • December 2017 (142)
  • November 2017 (122)
  • October 2017 (146)
  • September 2017 (178)
  • August 2017 (201)
  • July 2017 (222)
  • June 2017 (155)
  • May 2017 (205)
  • April 2017 (156)
  • March 2017 (178)
  • February 2017 (195)
  • January 2017 (149)
  • December 2016 (143)
  • November 2016 (169)
  • October 2016 (167)
  • September 2016 (137)
  • August 2016 (115)
  • July 2016 (117)
  • June 2016 (125)
  • May 2016 (171)
  • April 2016 (152)
  • March 2016 (201)
  • February 2016 (202)
  • January 2016 (217)
  • December 2015 (210)
  • November 2015 (177)
  • October 2015 (284)
  • September 2015 (243)
  • August 2015 (250)
  • July 2015 (188)
  • June 2015 (216)
  • May 2015 (281)
  • April 2015 (306)
  • March 2015 (297)
  • February 2015 (280)
  • January 2015 (245)
  • December 2014 (287)
  • November 2014 (254)
  • October 2014 (185)
  • September 2014 (98)
  • August 2014 (8)

Copyright © 2025 · News Pro Theme on Genesis Framework · WordPress · Log in